Lion's Mane (Hericium erinaceus)

Lion's Mane (Hericium erinaceus) is the undisputed frontrunner in the functional mushroom field for cognitive applications, distinguished by a unique dual mechanism of action no other fungus replicates at scale. Its fruiting body contains hericenones, aromatic compounds that stimulate the endogenous production of nerve growth factor (NGF) — a neurotrophin essential for the survival, maintenance, and repair of neurons in both the peripheral and central nervous systems. The mycelium contributes erinacines, particularly erinacine A, which are small enough to cross the blood-brain barrier and are considered the more potent NGF stimulators of the two compound classes. The clinical evidence base has matured substantially through 2025 and 2026. A landmark double-blind, randomized, placebo-controlled trial published in Frontiers in Nutrition (2025) administered 3 grams of standardized H. erinaceus fruiting body extract to 18 healthy adults aged 18–35 and documented significant improvements in psychomotor performance at 90 minutes post-dose. A separate 2023 MDPI Nutrients trial running 8 weeks demonstrated improved mood and reduced depression and anxiety scores with consistent supplementation. Animal models continue to show Erinacine A-enriched supplementation attenuates amyloid-beta plaque deposition in transgenic Alzheimer's mouse models — a mechanistic signal that human longitudinal trials are beginning to investigate. Optimal dosing for cognitive benefit sits between 500 mg and 3,000 mg of fruiting body extract daily, with most researchers recommending an 8–16-week minimum trial. Dual-extracted products standardized to a minimum of 25–30% beta-glucans represent the quality benchmark. Real Mushrooms' Organic Lion's Mane Extract Capsules (500 mg, 120 capsules, approximately $34.95) are certified third-party tested and contain verified hericenones — a rare transparency standard in the category. The Alzheimer's Drug Discovery Foundation rates Lion's Mane as 'promising/insufficient evidence' for Alzheimer's prevention, reflecting genuine mechanistic potential tempered by the need for larger-scale human trials. Safety profile is excellent: no significant adverse events have been reported in published trials at doses up to 3,000 mg daily for 16 weeks. Rare cases of allergic dermatitis have been documented in individuals with mold sensitivities.